*Some Market data delayed by 15 mins.

PAVmed Inc. Common Stock

Symbol: PAVM (NASDAQ)
0.43 0.00 0.000

Company Description:
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Key Stats
  • Today's Open: $0.431
  • Today's High: $0.431
  • Today's Low: $0.431
  • Today's Volume: 2
  • Yesterday Close: $0.431
  • Yesterday High: $0.456014
  • Yesterday Low: $0.4274
  • Yesterday Volume: 121.16K
  • Last Min Volume: 2
  • Last Min High: $0.431
  • Last Min Low: $0.431
  • Last Min VWAP: $0.431
Company Profile
  • Name: PAVmed Inc. Common Stock
  • Website: https://www.pavmed.com
  • Listed Date: 2016-04-28
  • Location: NEW YORK, NY
  • Market Status: Active
  • CIK Number: 0001624326
  • SIC Code: 3841
  • SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • Market Cap: $9.45M
  • Round Lot: 100
  • Outstanding Shares: 21.93M
  • Asset Type: CS
RECENT FILINGS FOR PAVM
Filing Date Filing Type Format
2025-09-11 8-K View
2025-08-14 SCHEDULE 13G View
2025-08-14 8-K View
2025-08-14 10-Q View
2025-07-30 8-K View
2025-07-28 S-8 View
2025-06-24 8-K View
2025-06-18 8-K View
2025-05-15 SCHEDULE 13G/A View
2025-05-15 8-K View
2025-05-15 10-Q View
2025-05-09 DEFA14A View
2025-04-30 DEFA14A View
2025-04-30 ARS View
2025-04-30 DEF 14A View
2025-04-30 25-NSE View
2025-04-25 8-K View
2025-04-21 424B3 View
2025-04-18 PRE 14A View
2025-04-17 EFFECT View
Latest News on PAVM

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.